American Society of Hematology

American Society of Hematology

The American Society of Hematology (ASH) is a professional organization dedicated to the study and treatment of blood disorders. Founded in 1958, ASH is the world's largest professional society concerned with the causes and treatments of blood diseases. Its membership includes more than 17,000 professionals from over 100 countries, encompassing physicians, scientists, and clinicians who are working to conquer blood diseases.

Mission and Vision[edit | edit source]

The mission of the American Society of Hematology is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

History[edit | edit source]

The society was established in 1958 by a group of hematologists led by Dr. William Dameshek. Since its inception, ASH has been at the forefront of advances in the field, from basic scientific research to clinical practices and patient care standards.

Annual Meeting[edit | edit source]

One of the highlights of ASH's activities is its annual meeting, which is the most comprehensive hematology event of the year. The meeting provides an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Attendees can network with top minds in the field and gain new perspectives on the critical aspects of hematology.

Publications[edit | edit source]

ASH publishes Blood, the most cited peer-reviewed publication in the field, which provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The society also publishes Blood Advances, an open-access, peer-reviewed journal that is available online only. Blood Advances publishes original research, unique insights in hematology, and debates on controversial issues.

Education and Training[edit | edit source]

ASH is committed to helping hematologists remain current in a rapidly changing field through continuing medical education (CME) opportunities. These include live events, online courses, and other materials designed to keep hematologists up-to-date on the latest research and clinical guidelines. The society also offers a range of awards and programs aimed at supporting hematologists at various stages of their careers, from students to seasoned professionals.

Advocacy[edit | edit source]

The society actively engages in advocacy efforts to advance the interests of hematologists and their patients. This includes lobbying for increased federal funding for hematology research and for policies that support the practice of hematology and the care of patients with hematologic diseases.

Membership[edit | edit source]

Membership in ASH is open to physicians, scientists, and other health professionals involved in the study and management of blood diseases. Members benefit from access to exclusive content, educational resources, and opportunities to participate in society activities.

Conclusion[edit | edit source]

The American Society of Hematology plays a pivotal role in advancing the field of hematology, fostering the development of innovative treatments, and improving patient care. Through its comprehensive programs and services, ASH continues to be a beacon of knowledge and a catalyst for breakthroughs in the study and treatment of blood disorders.